OVISA IVS: Financial statements 2019
CVR: 39889870
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
OVISA IVS (CVR 39889870) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 0 and a net result of DKK 0. Equity in the 2019 report amounted to DKK 0.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 0
- Equity
- DKK 0
- Total Assets
- DKK 0
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of January 1, 2019, Mathias Livbjerg has joined the board of directors of OVISA IVS.
As of January 1, 2019, Rasmus Røddik Davidsen has joined the board of directors of OVISA IVS.
As of January 1, 2019, Sigurd Peter von Arenstorff Vilstrup is registered as adm. dir. of OVISA IVS.
As of January 1, 2019, Sigurd Peter von Arenstorff Vilstrup is registered as chairman of OVISA IVS.
As of January 1, 2019, Lars Lippert Ovesen is registered as director of OVISA IVS.
As of January 1, 2019, Lars Lippert Ovesen is registered as vice chairman of OVISA IVS.
As of January 1, 2019, Mathias Livbjerg is registered as director of OVISA IVS.
As of January 1, 2019, Rasmus Røddik Davidsen is registered as director of OVISA IVS.
About OVISA IVS
OVISA IVS was a Danish company of the type Iværksætterselskab based in Aarhus N, founded in 2018. The company has been dissolved on 10 September 2021. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. In 2019, the company reported a gross profit of DKK 0 and a net result of DKK 0. Equity in the 2019 report amounted to DKK 0.